Tag:
EnteroMedics
Latest Headlines
Latest Headlines
EnteroMedics sees first product revenues
Last week, we profiled EnteroMedics' ($ETRM) seeming rise from the ashes. Today, it's reporting its first product revenues.
EnteroMedics claws its way back, nabs funding
MedCity News offers an interesting take this morning on EnteroMedics ($ETRM), which has seemingly come back from the brink of disaster and could one day see the FDA bless its obesity treatment Maestro.
EnteroMedics gets conditional OK for obesity study
EnteroMedics (NASDAQ: ETRM) has received conditional approval from the FDA for its IDE application outlining plans for studying the safety and efficacy of its obesity treatment. The announcement sent
